Industry Articles
Updates about sleep-related diagnostic devices, therapies, products and companies

FDA clears Fisher & Paykel Evora Full mask for OSA

On April 19, 2022, Fisher & Paykel Healthcare announced the U.S. launch of F&P Evora Full, a compact full-face mask for obstructive sleep apnea (OSA) treatment. The mask received FDA 510(k) clearance. About F&P Evora Full According to the company’s press release, the [...]

2024-09-24T21:52:48-05:00April 20th, 2022|Industry|

FDA clears Fitbit feature to detect A-fib

Google announced April 11, 2022, that Fitbit received FDA clearance for its photoplethysmography (PPG) algorithm to identify atrial fibrillation (A-fib). The algorithm will power Fitbit’s new irregular heart rhythm notification feature. About Fitbit’s PPG algorithm Fitbit’s PPG algorithm passively assesses heart rate while [...]

2024-09-24T21:54:24-05:00April 12th, 2022|Industry|

FDA clears wireless patch to detect sleep apnea

Wesper announced on Jan. 25, 2022, that it received FDA clearance for its Wesper Lab system, which assists trained personnel in the diagnosis of obstructive sleep apnea (OSA) with data from a wireless patch component. About Wesper Lab Wesper Lab is a digital [...]

2024-09-24T21:56:04-05:00January 26th, 2022|Industry|

Idorsia receives FDA approval of QUVIVIQ for insomnia

On Jan. 10, 2022, Idorsia announced that the FDA approved QUVIVIQ (daridorexant) 25 mg and 50 mg for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. About QUVIVIQ QUVIVIQ is a prescription medication indicated for [...]

2024-09-24T21:57:42-05:00January 11th, 2022|Industry|

Acurable receives FDA clearance for home sleep apnea testing device

On Nov. 30, 2021, Acurable announced it received FDA 510(k) clearance for its AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect obstructive sleep apnea (OSA) in adults. About AcuPebble SA100 AcuPebble SA100 senses, records and interprets a patient’s [...]

2024-09-24T21:58:28-05:00December 1st, 2021|Industry|

FDA clears Withings ScanWatch for atrial fibrillation detection

On Oct. 12, 2021, Withings announced its ScanWatch received FDA clearance to record electrocardiogram (ECG) and oxygen saturation (Sp02) measurements for atrial fibrillation detection. It also provides sleep tracking and analysis of sleep patterns. About ScanWatch ScanWatch is a wearable, Bluetooth-connected wrist-worn watch. [...]

2024-09-24T21:59:45-05:00October 13th, 2021|Industry|

FDA grants breakthrough device designation to Genio system for OSA

Nyxoah announced Sep. 14, 2021, that the FDA granted breakthrough device designation to its Genio bilateral hypoglossal nerve stimulation system, which is intended to treat adult patients with moderate to severe obstructive sleep apnea (OSA) and complete concentric collapse of the soft palate. About [...]

2024-09-24T22:05:09-05:00September 15th, 2021|Industry|

FDA authorizes Philips PAP device repair program

On Sept. 1, Philips announced that it has received authorization from the Food and Drug Administration to “rework” the recalled first-generation DreamStation devices by replacing the sound abatement foam with a new material. Philips anticipates that the repair program will begin this month. The [...]

2021-09-03T11:38:48-05:00September 2nd, 2021|Featured, Industry|
Go to Top